Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.
复制标题

DOI:
10.1038/onc.2013.157
复制
发表时间:
2014-04-24
期刊:
影响因子:
8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

基质金属蛋白酶-1(MMP-1)是肿瘤发生、炎症和组织重塑的重要介质,其降解关键基质成分的能力。最近的研究表明,基质来源的MMP 1可能发挥直接的致癌活性,通过蛋白酶激活受体1(PAR 1)在癌细胞中的信号转导,然而,这还没有在体内建立。我们产生了一个Mmp 1a基因敲除小鼠,以确定是否基质衍生的Mmp 1a影响肿瘤生长。Mmp 1a缺陷小鼠大体正常,出生时为孟德尔比率,然而,Mmp 1a缺陷导致肺肿瘤的生长和血管生成显著降低。肺癌细胞与野生型Mmp 1a +/+成纤维细胞的共植入完全恢复了Mmp 1a缺陷动物的肿瘤生长,突出了基质来源的Mmp 1a的关键作用。肺癌细胞中PAR 1表达的沉默表型模仿基质Mmp 1a缺陷,从而验证肿瘤来源的PAR 1作为Mmp 1a靶点。Mmp 1a的分泌受其前结构域抑制自切割的能力控制,而人MMP 1由于稳定的前结构域和催化结构域相互作用而有效分泌。总之,这些数据表明基质Mmp 1a驱动体内肿瘤发生,并提供了靶向MMP 1-PAR 1轴可以提供有效治疗肺癌的概念验证。
Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in carcinoma cells, however, this has not been established in vivo. We generated a Mmp1a knock-out mouse to ascertain whether stromal-derived Mmp1a affects tumor growth. Mmp1a-deficient mice are grossly normal and born in Mendelian ratios, however, deficiency of Mmp1a results in significantly decreased growth and angiogenesis of lung tumors. Co-implantation of lung cancer cells with wild-type Mmp1a+/+ fibroblasts completely restored tumor growth in Mmp1a-deficient animals, highlighting the critical role of stromal-derived Mmp1a. Silencing of PAR1 expression in the lung carcinoma cells phenocopied stromal Mmp1a-deficiency, thus validating tumor-derived PAR1 as a Mmp1a target. Mmp1a secretion is controlled by the ability of its prodomain to suppress auto-cleavage, whereas human MMP1 is efficiently secreted due to stable pro- and catalytic domain interactions. Together, these data demonstrate that stromal Mmp1a drives in vivo tumorigenesis and provide proof-of-concept that targeting the MMP1-PAR1 axis may afford effective treatments of lung cancer.
DOI: 10.1158/0008-5472.can-05-2082
发表时间: 2006-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Nguyen, N;Kuliopulos, A;Covic, L
通讯作者: Covic, L
DOI: 10.1158/0008-5472.can-05-3897
发表时间: 2006-08-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Goerge, Tobias;Barg, Alexej;Schneider, Stefan W.
通讯作者: Schneider, Stefan W.
DOI: 10.1016/0304-3835(80)90130-5
发表时间: 1980-01-01
期刊: CANCER LETTERS
影响因子: 9.7
作者:
BERTRAM, JS;JANIK, P
通讯作者: JANIK, P
DOI: 10.1038/ng1249
发表时间: 2003-11-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Balbín, M;Fueyo, A;López-Otín, C
通讯作者: López-Otín, C
DOI: 10.1074/jbc.m411084200
发表时间: 2005-03-11
影响因子: 4.8
作者:
Jozic, D;Bourenkov, G;Maskos, K
通讯作者: Maskos, K